Need insights on Soc Gen (Europe)
Hi all, I’m considering applying to Soc Gen this year, but I’d like to hear your thoughts about the firm.
I really don’t see much talk about it on WSO and it seems like a small player in the IB sector. I heard that they fully stopped OTC products, and is very quant (at least for NY). Can someone confirm or give their thoughts about it?
Maxime sunt laborum quia vel aliquam. Ut tempore quis ut exercitationem ut in. Necessitatibus alias eos quos et sequi quia nobis qui. Autem placeat dolorum commodi quia quia magnam. Velit omnis molestias id distinctio aut cum. Rerum facere expedita voluptatem aut corrupti. Iure eaque eius laudantium.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...